Flutter Entertainment R&D increased by 5.7% to $259.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $215.00M to $259.00M. Over 3 years (FY 2022 to FY 2025), R&D shows an upward trend with a 21.5% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.00M | $138.00M | $138.00M | $138.00M | $168.00M | $176.00M | $214.00M | $207.00M | $190.00M | $216.00M | $213.00M | $201.00M | $215.00M | $256.00M | $275.00M | $245.00M | $259.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +21.7% | +4.8% | +21.6% | -3.3% | -8.2% | +13.7% | -1.4% | -5.6% | +7.0% | +19.1% | +7.4% | -10.9% | +5.7% |
| YoY Change | — | — | — | — | +21.7% | +27.5% | +55.1% | +50.0% | +13.1% | +22.7% | -0.5% | -2.9% | +13.2% | +18.5% | +29.1% | +21.9% | +20.5% |